Recognition of Impaired Atomoxetine Metabolism Because of Low CYP2D6 ActivityTER LAAK, Maureen A; TEMMINK, Alphons H; KOEKEN, Ankie et al.Pediatric neurology. 2010, Vol 43, Num 3, pp 159-162, issn 0887-8994, 4 p.Article

Atomoxetine treatment of attention-deficit/hyperactivity disorderEILAND, Lea S; GUEST, Abby L.The Annals of pharmacotherapy. 2004, Vol 38, Num 1, pp 86-90, issn 1060-0280, 5 p.Article

Atomoxetine in the Treatment of Adults with Subthreshold and/or Late Onset Attention-Deficit Hyperactivity Disorder-Not Otherwise Specified (ADHD-NOS): A Prospective Open-Label 6-Week StudySURMAN, Craig; HAMMERNESS, Paul; PETTY, Carter et al.CNS neuroscience & therapeutics (Print). 2010, Vol 16, Num 1, pp 6-12, issn 1755-5930, 7 p.Article

Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHDDONNELLY, Craig; BANGS, Mark; TRZEPACZ, Paula et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2009, Vol 48, Num 2, pp 176-185, issn 0890-8567, 10 p.Article

Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetineSOBANSKI, E; SABLJIC, D; ALM, B et al.European psychiatry. 2013, Vol 28, Num 6, pp 379-385, issn 0924-9338, 7 p.Article

VARIABLE PRENATAL STRESS RESULTS IN IMPAIRMENTS OF SUSTAINED ATTENTION AND INHIBITORY RESPONSE CONTROL IN A 5-CHOICE SERIAL REACTION TIME TASK IN RATSWILSON, C. A; SCHADE, R; TERRY, A. V et al.Neuroscience. 2012, Vol 218, pp 126-137, issn 0306-4522, 12 p.Article

Structural determination of the stable and meta-stable forms of atomoxetine HCl using single crystal and powder X-ray diffraction methodsSTEPHENSON, Gregory A; CIKUI LIANG.Journal of pharmaceutical sciences. 2006, Vol 95, Num 8, pp 1677-1683, issn 0022-3549, 7 p.Article

Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled AnalysisADLER, Lenard A; WILENS, Timothy; SHUYU ZHANG et al.Clinical therapeutics. 2012, Vol 34, Num 2, pp 363-373, issn 0149-2918, 11 p.Article

Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and MetaregressionSCHWARTZ, Shimon; CORRELL, Christoph U.Journal of the American Academy of Child and Adolescent Psychiatry. 2014, Vol 53, Num 2, pp 174-187, issn 0890-8567, 14 p.Article

An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorderTAKAHASHI, Michihiro; TAKITA, Yasushi; GOTO, Taro et al.Psychiatry and clinical neurosciences (Carlton. Print). 2011, Vol 65, Num 1, pp 55-63, issn 1323-1316, 9 p.Article

Atomoxetine for freezing of gait in Parkinson diseaseJANKOVIC, Joseph.Journal of the neurological sciences. 2009, Vol 284, Num 1-2, pp 177-178, issn 0022-510X, 2 p.Article

High-dose atomoxetine treatment of ADHD in youths with limited response to standard dosesKRATOCHVIL, Christopher J; MICHELSON, David; SAYLOR, Keith E et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2007, Vol 46, Num 9, pp 1128-1137, issn 0890-8567, 10 p.Article

Randomized, Controlled Trial of Atomoxetine for Attention-Deficit/ Hyperactivity Disorder in Adolescents With Substance Use DisorderTHURSTONE, Christian; RIGGS, Paula D; SALOMONSEN-SAUTEL, Stacy et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2010, Vol 49, Num 6, pp 573-582, issn 0890-8567, 10 p.Article

Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder : The Integrated Data Exploratory Analysis (IDEA) StudyNEWCORN, Jeffrey H; SUTTON, Virginia K; WEISS, Margaret D et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2009, Vol 48, Num 5, pp 511-518, issn 0890-8567, 8 p.Article

Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioningDAVIS, Jennifer A; GOULD, Thomas J.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 9, pp 2011-2019, issn 0893-133X, 9 p.Article

Atomoxetine Tolerability in Pediatric and Adult Patients Receiving Different Dosing StrategiesWIETECHA, Linda A; RUFF, Dustin D; ALLEN, Albert J et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 12, pp 1217-1223, issn 0160-6689, 7 p.Article

Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHDDING, Y.-S; NAGANAWA, M; LARUELLE, M et al.NeuroImage (Orlando, Fla.). 2014, Vol 86, pp 164-171, issn 1053-8119, 8 p.Article

High Impulsivity Predicts Relapse to Cocaine-Seeking After Punishment-Induced AbstinenceECONOMIDOU, Daina; PELLOUX, Yann; ROBBINS, Trevor W et al.Biological psychiatry (1969). 2009, Vol 65, Num 10, pp 851-856, issn 0006-3223, 6 p.Article

Atomoxetine and Cerebrovascular Outcomes in AdultsHOLICK, Crystal N; TURNBULL, Bruce R; JONES, Meghan E et al.Journal of clinical psychopharmacology. 2009, Vol 29, Num 5, pp 453-460, issn 0271-0749, 8 p.Article

Augmentation with open-label atomoxetine for partial or nonresponse to antidepressantsCARPENTER, Linda L; MILOSAVLJEVIC, Nada; SCHECTER, Jordan M et al.The Journal of clinical psychiatry. 2005, Vol 66, Num 10, pp 1234-1238, issn 0160-6689, 5 p.Article

Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetineGREENHILL, Laurence L; NEWCORN, Jeffrey H; HAITAO GAO et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2007, Vol 46, Num 5, pp 566-572, issn 0890-8567, 7 p.Article

Adjunctive atomoxetine for residual fatigue in major depressive disorderPAPAKOSTAS, George I; PETERSEN, Timothy J; BURNS, Alana M et al.Journal of psychiatric research. 2006, Vol 40, Num 4, pp 370-373, issn 0022-3956, 4 p.Article

Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trialsASHERSON, Philip; BUSHE, Chris; SAYLOR, Keith et al.Journal of psychopharmacology (Oxford). 2014, Vol 28, Num 9, pp 837-846, issn 0269-8811, 10 p.Article

Evaluation of a head-to-head study of lisdexamfetamine dimesylate and atomoxetineBANASCHEWSKI, Tobias; ROTHERMEL, Boris; POUSTKA, Luise et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 13, pp 1961-1965, issn 1465-6566, 5 p.Article

Atomoxetine for the Treatment of Executive Dysfunction in Parkinson's Disease : A Pilot Open-Label StudyMARSH, Laura; BIGLAN, Kevin; GERSTENHABER, Melissa et al.Movement disorders. 2009, Vol 24, Num 2, pp 277-282, issn 0885-3185, 6 p.Article